During 10 years of follow up, 100 adverse cardiovascular events occurred in patients in the study. (sciencedaily.com)
Sexual activity was not a risk factor for subsequent adverse cardiovascular events. (sciencedaily.com)
The Xarelto partnership is seeking additional approved uses, with trials underway in patients with acute coronary syndrome, and for reduction of major adverse cardiovascular events in patients with heart failure or peripheral artery disease. (reuters.com)